Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1981 1
1987 1
1997 1
1998 1
1999 1
2001 2
2002 3
2003 2
2004 1
2005 1
2007 1
2008 1
2009 1
2016 1
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation"
Page 1
Prognostic factors and indications for treatment of Waldenstrom's Macroglobulinemia.
Kyle RA, Ansell SM, Kapoor P. Kyle RA, et al. Best Pract Res Clin Haematol. 2016 Jun;29(2):179-186. doi: 10.1016/j.beha.2016.08.014. Epub 2016 Aug 23. Best Pract Res Clin Haematol. 2016. PMID: 27825464 Free PMC article. Review.
Waldenstrom's Macroglobulinemia (WM) is characterized by the presence of an IgM monoclonal protein regardless of its size, 10% or more bone marrow infiltration by small lymphocytes with a plasmacytoid or plasma cell differentiation. These cells usually have t …
Waldenstrom's Macroglobulinemia (WM) is characterized by the presence of an IgM monoclonal protein regardless of its size, 10% or more bone …
Blastic plasmacytoid dendritic cell neoplasm in the background of myeloproliferative disorder and chronic lymphocytic leukaemia.
Khan AM, Munir A, Raval M, Mehdi S. Khan AM, et al. BMJ Case Rep. 2019 Jul 15;12(7):e230332. doi: 10.1136/bcr-2019-230332. BMJ Case Rep. 2019. PMID: 31308179 Free PMC article. Review.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare haematological malignancy defined by concurrent expression of CD4, CD56, BCL-2 and CD123. The disease has a very poor prognosis and there are no well-established treatment guidelines. W …
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare haematological malignancy defined by concurrent expr …
Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
Asaad NY, Abd El-Wahed MM, Dawoud MM. Asaad NY, et al. J Egypt Natl Canc Inst. 2005 Dec;17(4):279-90. J Egypt Natl Canc Inst. 2005. PMID: 17102815
BACKGROUND: B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL) show many overlapping morphologic and immunophenotyping features, however they have great difference in therapeu …
BACKGROUND: B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma (B-CLL/SLL) and mantle …
"Well-differentiated" lymphocytic neoplasms. Immunologic findings correlated with clinical presentation and morphologic features.
Medeiros LJ, Strickler JG, Picker LJ, Gelb AB, Weiss LM, Warnke RA. Medeiros LJ, et al. Am J Pathol. 1987 Dec;129(3):523-35. Am J Pathol. 1987. PMID: 3322023 Free PMC article.
The authors studied 48 cases of well-differentiated lymphocytic neoplasms using a panel of monoclonal antibodies applied to frozen sections. ...In contrast to the markedly different clinical presentation and morphologic appearance these tumors may have, the immunolo …
The authors studied 48 cases of well-differentiated lymphocytic neoplasms using a panel of monoclonal antibodies applied to fr …
Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.
Jilani I, Wei C, Bekele BN, Zhang ZJ, Keating M, Wierda W, Ferrajoli A, Estrov Z, Kantarjian H, O'Brien SM, Giles FJ, Albitar M. Jilani I, et al. Int J Lab Hematol. 2009 Feb;31(1):97-105. doi: 10.1111/j.1751-553X.2007.01010.x. Epub 2008 Jan 7. Int J Lab Hematol. 2009. PMID: 18190591 Free PMC article.
Syndecan-1 (sCD138) is a transmembrane heparan sulfate-bearing proteoglycan expressed in epithelial cells as well as hematopoietic cells that demonstrate plasmacytoid differentiation. Higher levels of sCD138 correlate with poor outcome in myeloma. We examined the as …
Syndecan-1 (sCD138) is a transmembrane heparan sulfate-bearing proteoglycan expressed in epithelial cells as well as hematopoietic cells tha …
A review of Waldenstrom's macroglobulinemia.
McDermott MK, Bell EM. McDermott MK, et al. Clin J Oncol Nurs. 1999 Jul;3(3):107-11. Clin J Oncol Nurs. 1999. PMID: 10690041 Review.
Waldenstrom's macroglobulinemia (WM) is an uncommon B cell malignancy that resembles other B cell malignancies, such as multiple myeloma and chronic lymphocytic leukemia. WM's clinical course varies widely, with survival ran …
Waldenstrom's macroglobulinemia (WM) is an uncommon B cell malignancy that resembles other B cell malignancies, …
Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
Moore EM, Swerdlow SH, Gibson SE. Moore EM, et al. Am J Surg Pathol. 2018 Mar;42(3):342-350. doi: 10.1097/PAS.0000000000001015. Am J Surg Pathol. 2018. PMID: 29309299
Its role in the differential diagnosis of B-cell lymphomas, particularly in the distinction of follicular lymphoma (FL) versus marginal zone lymphoma (MZL), remains to be determined. ...MEF2B was positive in all FL and Burkitt lymphomas, 8/9 mantle cell …
Its role in the differential diagnosis of B-cell lymphomas, particularly in the distinction of follicular lymphoma (FL) …
Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias: studies of chronic and acute lymphocytic, prolymphocytic, lymphosarcoma cell and hairy cell leukemia, Sezary's syndrome, and other lymphoid leukemias.
Said JW, Pinkus GS. Said JW, et al. Cancer. 1981 Dec 15;48(12):2630-42. doi: 10.1002/1097-0142(19811215)48:12<2630::aid-cncr2820481215>3.0.co;2-p. Cancer. 1981. PMID: 6975649
B-cell leukemias (comprised 82% of the series and included chronic lymphocytic leukemia (69/71 cases), acute lymphocytic leukemia (1/18 cases), lymphosarcoma cell leukemia (15/18 cases), prolymphocytic leukemia …
B-cell leukemias (comprised 82% of the series and included chronic lymphocytic leukemia (69/71 cases), ac …
Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases.
Andriko JA, Swerdlow SH, Aguilera NI, Abbondanzo SL. Andriko JA, et al. Am J Surg Pathol. 2001 Jun;25(6):742-51. doi: 10.1097/00000478-200106000-00005. Am J Surg Pathol. 2001. PMID: 11395551
Lymphoplasmacytic lymphoma/immunocytoma (LLI) was defined initially as a small B-cell lymphoma with plasmacytoid or plasmacytic features. Because other types of small B-cell lymphoma, particularly marginal zone B-cell lymphoma may …
Lymphoplasmacytic lymphoma/immunocytoma (LLI) was defined initially as a small B-cell lymphoma with plasmacytoid or pla …
Malignant lymphoma, small lymphocytic type: a clinicopathologic study of 84 cases with suggested criteria for intermediate lymphocytic lymphoma.
Evans HL, Butler JJ, Youness EL. Evans HL, et al. Cancer. 1978 Apr;41(4):1440-55. doi: 10.1002/1097-0142(197804)41:4<1440::aid-cncr2820410432>3.0.co;2-g. Cancer. 1978. PMID: 76506
Clinical and histopathologic findings were reviewed in 84 cases of malignant lymphoma of the small (well differentiated) lymphocytic type. The slides were studied without clinical information, and the following morphologic features were evaluated: pattern of growth, …
Clinical and histopathologic findings were reviewed in 84 cases of malignant lymphoma of the small (well differentiated) lymphocyt …
19 results